Physical Fitness and Body Composition in Transgender vs. Cisgender Individuals: A Systematic Review and Meta-Analysis
Authors:
- Sofia Mendes SieczkowskaSSSofia Mendes Sieczkowska
- Bruna Caruso MazzolaniBMBruna Caruso Mazzolani
- Danilo Reis CoimbraDCDanilo Reis Coimbra
- Igor LongobardiIgor Longobardi
- Andresa Rossilho CasaleACAndresa Rossilho Casale
- Jose Davi Fajardo Villela Martins Pompilio da HoraJHJose Davi Fajardo Villela Martins Pompilio da Hora
- Hamilton RoschelHamilton Roschel
- Bruno GualanoBGBruno Gualano
Preprint
Abstract
Objective: To compare fitness and body composition between transgender and cisgender individuals. Design: Systematic review and meta-analysis. Data sources: PubMed, Web of Science, Embase, and SportDiscus databases were searched in June 2024, supplemented by manual citation reviews. Eligibility criteria: Inclusion criteria comprised studies of transgender individuals comparing physical fitness/body composition pre-to-post gender-affirming hormone therapy (GAHT) or vs. cisgender controls, with quantitative outcomes reported. Results: Fifty-one studies (6,434 participants) were analyzed. Transgender women (TW) exhibited comparable fat mass to cisgender women (CW), but higher than cisgender men (CM). TW showed greater lean mass than CW, but lower than CM. Upper- and lower-body strength were similar between TW and CW, but lower than CM. TW and CW had similar VO 2 peak, but TW exhibited lower values than CM. Transgender men (TM) exhibited similar fat mass to CW, but higher than CM. TM showed higher lean mass than CW, but lower than CM. Upper-body strength was higher in TM than CW, but lower than CM. GAHT in TW increased fat mass, reduced lean mass and upper-body strength, with no differences in lower-body strength over 1–3 years. TM demonstrated reduced fat mass and increased lean mass, upper- and lower-body strength post-GAHT. Risk of bias was moderate for most studies, with limited observations for specific outcomes (e.g., VO 2 peak). Conclusion: While TW exhibited higher lean mass than CW, their physical fitness was comparable. Current evidence is limited but does not justify blanket bans based on assumptions of inherent athletic advantages for TW over CW. WHAT IS ALREADY KNOWN ON THIS TOPIC: The inclusion of transgender women in female sports categories remains a highly contentious subject. Existing studies suggest that gender-affirming hormone therapy (GAHT) alters body composition in transgender individuals, but evidence on functional performance outcomes (e.g., strength, endurance) remains inconsistent. Policies advocating blanket bans on transgender women (TW) in female sports often cite residual advantages from prior testosterone exposure, despite limited empirical support for sustained performance disparities post-GAHT. WHAT THIS STUDY ADDS?: This systematic review and meta-analysis synthesizes data from 51 studies (6,434 participants), demonstrating that, while TW showed higher absolute lean mass than cisgender women (CW), there are no significant differences in upper/lower-body strength or VO□peak after 1–3 years of GAHT. These findings challenge the validity of blanket bans predicated on assumptions of inherent athletic superiority of TW over CW. Transgender men (TM) exhibit body composition and strength metrics intermediate between CW and cisgender men (CM) post-GAHT. Critical research gaps are identified, including a lack of long-term GAHT data, underrepresentation of transgender athletes, and inconsistent controls for confounders (e.g., training history, puberty blocking). Future studies must prioritize sport-specific performance metrics and longitudinal designs to inform equitable policies.Keywords
This publication has 65 references indexed in Scilit:
- Cross-cultural differences in trait emotional intelligence: A meta-analysisPersonality and Individual Differences, 2025
- Body composition and risk for sarcopenia in transgender womenNutrition, 2024
- Bone mineral density, trabecular bone score and muscle strength in transgender men receiving testosterone therapy versus cisgender menSteroids, 2022
- A Randomized Double-Blind Placebo-Controlled Pilot Trial on the Effects of Testosterone Undecanoate Plus Dutasteride or Placebo on Muscle Strength, Body Composition, and Metabolic Profile in TransmenThe Journal of Sexual Medicine, 2021
- Early Hormonal Treatment Affects Body Composition and Body Shape in Young Transgender AdolescentsThe Journal of Sexual Medicine, 2018
- Stigma and Minority Stress as Social Determinants of Health Among Lesbian, Gay, Bisexual, and Transgender YouthPediatric Clinics of North America, 2016
- Network Meta-Analysis2015
- Preservation of volumetric bone density and geometry in trans women during cross-sex hormonal therapy: a prospective observational studyOsteoporosis International, 2014
- Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomyBone, 2013
- Body composition, volumetric and areal bone parameters in male-to-female transsexual personsBone, 2008